Pacific Biosciences of California, Inc. (PACB)
USD 1.85
(-6.09%)
USD 1.85
(-6.09%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 933.93 Million USD | -2.45% |
| 2022 | 957.36 Million USD | 0.38% |
| 2021 | 953.74 Million USD | 2170.88% |
| 2020 | 41.99 Million USD | -31.9% |
| 2019 | 61.67 Million USD | 320.71% |
| 2018 | 14.65 Million USD | 7.51% |
| 2017 | 13.63 Million USD | -15.34% |
| 2016 | 16.1 Million USD | 7.75% |
| 2015 | 14.94 Million USD | 5.83% |
| 2014 | 14.12 Million USD | -11.5% |
| 2013 | 15.96 Million USD | 472.86% |
| 2012 | 2.78 Million USD | -4.78% |
| 2011 | 2.92 Million USD | -3.65% |
| 2010 | 3.03 Million USD | 0.0% |
| 2009 | - USD | -100.0% |
| 2008 | 1.3 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 931.36 Million USD | -0.27% |
| 2024 Q2 | 924.95 Million USD | -0.69% |
| 2023 FY | 933.93 Million USD | -2.45% |
| 2023 Q2 | 937.63 Million USD | -0.76% |
| 2023 Q3 | 935.55 Million USD | -0.22% |
| 2023 Q4 | 933.93 Million USD | -0.17% |
| 2023 Q1 | 944.82 Million USD | -1.31% |
| 2022 Q3 | 948.3 Million USD | -0.2% |
| 2022 Q4 | 957.36 Million USD | 0.96% |
| 2022 FY | 957.36 Million USD | 0.38% |
| 2022 Q1 | 952.01 Million USD | -0.18% |
| 2022 Q2 | 950.22 Million USD | -0.19% |
| 2021 Q2 | 935.83 Million USD | -0.08% |
| 2021 Q3 | 952.99 Million USD | 1.83% |
| 2021 Q4 | 953.74 Million USD | 0.08% |
| 2021 FY | 953.74 Million USD | 2170.88% |
| 2021 Q1 | 936.6 Million USD | 2130.07% |
| 2020 Q3 | 43.01 Million USD | -2.17% |
| 2020 Q2 | 43.96 Million USD | -2.01% |
| 2020 Q1 | 44.87 Million USD | -27.24% |
| 2020 Q4 | 41.99 Million USD | -2.35% |
| 2020 FY | 41.99 Million USD | -31.9% |
| 2019 Q1 | 63.32 Million USD | 331.95% |
| 2019 Q3 | 62.23 Million USD | -0.87% |
| 2019 FY | 61.67 Million USD | 320.71% |
| 2019 Q4 | 61.67 Million USD | -0.91% |
| 2019 Q2 | 62.78 Million USD | -0.84% |
| 2018 Q4 | 14.65 Million USD | 1.91% |
| 2018 FY | 14.65 Million USD | 7.51% |
| 2018 Q3 | 14.38 Million USD | 1.86% |
| 2018 Q1 | 13.87 Million USD | 1.74% |
| 2018 Q2 | 14.12 Million USD | 1.79% |
| 2017 Q3 | 13.36 Million USD | 2.13% |
| 2017 FY | 13.63 Million USD | -15.34% |
| 2017 Q4 | 13.63 Million USD | 2.04% |
| 2017 Q1 | 16.42 Million USD | 1.98% |
| 2017 Q2 | 13.08 Million USD | -20.34% |
| 2016 Q3 | 15.79 Million USD | 1.92% |
| 2016 FY | 16.1 Million USD | 7.75% |
| 2016 Q1 | 15.21 Million USD | 1.79% |
| 2016 Q2 | 15.49 Million USD | 1.84% |
| 2016 Q4 | 16.1 Million USD | 1.98% |
| 2015 Q4 | 14.94 Million USD | 0.95% |
| 2015 Q2 | 14.56 Million USD | 1.59% |
| 2015 Q1 | 14.33 Million USD | 1.52% |
| 2015 FY | 14.94 Million USD | 5.83% |
| 2015 Q3 | 14.8 Million USD | 1.65% |
| 2014 Q4 | 14.12 Million USD | 1.51% |
| 2014 Q3 | 13.91 Million USD | 1.46% |
| 2014 Q2 | 13.71 Million USD | -19.01% |
| 2014 FY | 14.12 Million USD | -11.5% |
| 2014 Q1 | 16.93 Million USD | 6.09% |
| 2013 Q2 | 17.89 Million USD | 14.71% |
| 2013 Q4 | 15.96 Million USD | -6.17% |
| 2013 Q3 | 17 Million USD | -4.94% |
| 2013 Q1 | 15.59 Million USD | 459.87% |
| 2013 FY | 15.96 Million USD | 472.86% |
| 2012 FY | 2.78 Million USD | -4.78% |
| 2012 Q4 | 2.78 Million USD | -1.35% |
| 2012 Q3 | 2.82 Million USD | -1.29% |
| 2012 Q2 | 2.86 Million USD | -1.17% |
| 2012 Q1 | 2.89 Million USD | -1.06% |
| 2011 Q2 | 2.98 Million USD | -0.9% |
| 2011 Q1 | 3.01 Million USD | -0.79% |
| 2011 Q4 | 2.92 Million USD | -1.01% |
| 2011 Q3 | 2.95 Million USD | -1.0% |
| 2011 FY | 2.92 Million USD | -3.65% |
| 2010 FY | 3.03 Million USD | 0.0% |
| 2010 Q3 | 3.05 Million USD | 4903.28% |
| 2010 Q2 | 61 Thousand USD | 0.0% |
| 2010 Q4 | 3.03 Million USD | -0.49% |
| 2009 FY | - USD | -100.0% |
| 2009 Q4 | - USD | 0.0% |
| 2008 FY | 1.3 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Alphatec Holdings, Inc. | 541.67 Million USD | -72.414% |
| Nemaura Medical Inc. | 20.03 Million USD | -4562.621% |
| NeuroPace, Inc. | 72.39 Million USD | -1190.048% |
| LENSAR, Inc. | 2.3 Million USD | -40347.38% |
| TriSalus Life Sciences, Inc. | 1.59 Million USD | -58453.605% |
| Apyx Medical Corporation | 38.5 Million USD | -2325.729% |
| Cutera, Inc. | 431.91 Million USD | -116.232% |
| STRATA Skin Sciences, Inc. | 15.63 Million USD | -5874.093% |
| BioSig Technologies, Inc. | 452 Thousand USD | -206521.681% |
| Talis Biomedical Corporation | 19.66 Million USD | -4648.475% |
| Integra LifeSciences Holdings Corporation | 1.68 Billion USD | 44.465% |
| Cerus Corporation | 95.99 Million USD | -872.854% |
| Axonics, Inc. | 27.61 Million USD | -3281.721% |
| Treace Medical Concepts, Inc. | 70.3 Million USD | -1228.435% |
| Outset Medical, Inc. | 136.18 Million USD | -585.765% |
| IRIDEX Corporation | 2.74 Million USD | -33910.561% |
| PROCEPT BioRobotics Corporation | 79.2 Million USD | -1079.145% |
| TELA Bio, Inc. | 42.78 Million USD | -2083.1% |
| Tivic Health Systems, Inc. | 369 Thousand USD | -252997.561% |
| RxSight, Inc. | 3.01 Million USD | -30906.972% |
| INVO Bioscience, Inc. | 8.68 Million USD | -10655.15% |
| electroCore, Inc. | 626 Thousand USD | -149090.096% |
| Telesis Bio, Inc. | 34.38 Million USD | -2616.492% |
| Viemed Healthcare, Inc. | 10.27 Million USD | -8992.724% |
| Quipt Home Medical Corp. | 98.94 Million USD | -843.902% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -39675.554% |
| Pulmonx Corporation | 41.42 Million USD | -2154.563% |
| Lucid Diagnostics Inc. | 15.25 Million USD | -6022.124% |
| Dynatronics Corporation | 6.68 Million USD | -13864.367% |
| Modular Medical, Inc. | 1.19 Million USD | -78381.513% |
| ReShape Lifesciences Inc. | 262 Thousand USD | -356361.832% |
| PetVivo Holdings, Inc. | 1.36 Million USD | -68317.775% |
| LivaNova PLC | 640.4 Million USD | -45.835% |
| Rapid Micro Biosystems, Inc. | 7.34 Million USD | -12613.449% |
| InMode Ltd. | 9.01 Million USD | -10257.436% |
| Accelerate Diagnostics, Inc. | 39.22 Million USD | -2281.26% |
| Envoy Medical, Inc. | 404 Thousand USD | -231070.792% |
| Bruker Corporation | 1.37 Billion USD | 32.304% |
| Helius Medical Technologies, Inc. | 57 Thousand USD | -1638373.684% |
| DexCom, Inc. | 2.59 Billion USD | 63.997% |
| Align Technology, Inc. | 96.96 Million USD | -863.132% |
| Nexalin Technology, Inc. | 4463.00 USD | -20925958.705% |
| Anika Therapeutics, Inc. | 29.03 Million USD | -3116.345% |
| PAVmed Inc | 48.72 Million USD | -1816.737% |
| Viveve Medical, Inc. | 5.34 Million USD | -17359.899% |
| Movano Inc. | 252 Thousand USD | -370507.143% |
| Cytek Biosciences, Inc. | 33.17 Million USD | -2715.247% |
| NeuroOne Medical Technologies Corporation | 184.4 Thousand USD | -506369.631% |
| 908 Devices Inc. | 5.94 Million USD | -15609.504% |
| Nexalin Technology, Inc. | 4463.00 USD | -20925958.705% |
| IceCure Medical Ltd | 599 Thousand USD | -155814.858% |
| Tandem Diabetes Care, Inc. | 415.66 Million USD | -124.682% |
| Venus Concept Inc. | 79.69 Million USD | -1071.851% |
| Profound Medical Corp. | 7.9 Million USD | -11721.344% |
| enVVeno Medical Corporation | 1.4 Million USD | -66514.123% |
| ClearPoint Neuro, Inc. | 13.94 Million USD | -6599.161% |
| Orthofix Medical Inc. | 134.19 Million USD | -595.929% |
| Surmodics, Inc. | 29.4 Million USD | -3076.093% |
| iCAD, Inc. | 461 Thousand USD | -202487.852% |
| Nuwellis, Inc. | 981 Thousand USD | -95101.835% |
| IRadimed Corporation | 2.04 Million USD | -45612.694% |
| OrthoPediatrics Corp. | 23.76 Million USD | -3830.682% |
| SI-BONE, Inc. | 38.99 Million USD | -2295.184% |
| Semler Scientific, Inc. | 70 Thousand USD | -1334085.714% |
| iRhythm Technologies, Inc. | 129.82 Million USD | -619.382% |
| Biotricity, Inc. | 23.87 Million USD | -3811.128% |
| Nano-X Imaging Ltd. | 8.39 Million USD | -11023.511% |
| Aethlon Medical, Inc. | 940.31 Thousand USD | -99220.867% |
| Cytosorbents Corporation | 18.31 Million USD | -4999.777% |
| Inogen, Inc. | 21.92 Million USD | -4160.047% |
| MaxCyte, Inc. | 18.74 Million USD | -4882.82% |
| ZimVie Inc. | 521.92 Million USD | -78.938% |
| PAVmed Inc. | 48.72 Million USD | -1816.737% |
| DIH Holding US, Inc. Warrants | 1.99 Million USD | -46678.362% |
| DIH Holdings US, Inc. Class A Common Stock | 1.99 Million USD | -46678.362% |
| Sight Sciences, Inc. | 35.41 Million USD | -2537.177% |
| Insulet Corporation | 1.44 Billion USD | 35.538% |
| Monogram Orthopaedics, Inc. | 491.99 Thousand USD | -189726.643% |
| Beyond Air, Inc. | 17.83 Million USD | -5135.914% |
| FONAR Corporation | 41.67 Million USD | -2140.937% |
| AxoGen, Inc. | 69.29 Million USD | -1247.818% |
| Bioventus Inc. | 409.47 Million USD | -128.079% |
| Tactile Systems Technology, Inc. | 50.37 Million USD | -1753.955% |
| Inari Medical, Inc. | 32.04 Million USD | -2814.251% |
| InspireMD, Inc. | 1.59 Million USD | -58453.605% |
| UFP Technologies, Inc. | 46.03 Million USD | -1928.651% |
| QT Imaging Holdings, Inc. | 3.07 Million USD | -30310.653% |
| Heart Test Laboratories, Inc. | 1.03 Million USD | -90018.282% |
| BrainsWay Ltd. | 471 Thousand USD | -198186.624% |
| BIOLASE, Inc. | 17.91 Million USD | -5114.573% |
| Tenon Medical, Inc. | 1.17 Million USD | -79518.926% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -93106.587% |
| CVRx, Inc. | 30.61 Million USD | -2950.763% |
| AdaptHealth Corp. | 2.29 Billion USD | 59.3% |
| Sintx Technologies, Inc. | 4.24 Million USD | -21900.707% |
| Vivos Therapeutics, Inc. | 1.99 Million USD | -46713.534% |
| NanoVibronix, Inc. | 5000.00 USD | -18678500.0% |
| Quanterix Corporation | 41.46 Million USD | -2152.388% |
| Acutus Medical, Inc. | 38.47 Million USD | -2327.116% |
| Co-Diagnostics, Inc. | 2.99 Million USD | -31129.195% |
| Varex Imaging Corporation | 469.5 Million USD | -98.92% |
| Vivani Medical, Inc. | 20.69 Million USD | -4412.611% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -39675.554% |
| Sensus Healthcare, Inc. | 783 Thousand USD | -119175.862% |
| TransMedics Group, Inc. | 515.94 Million USD | -81.013% |
| ReWalk Robotics Ltd. | 1.9 Million USD | -48976.721% |
| NeuroMetrix, Inc. | 240.87 Thousand USD | -387622.314% |
| Spectral AI, Inc. | 1.28 Million USD | -72353.84% |
| Hyperfine, Inc. | 185 Thousand USD | -504727.027% |
| Establishment Labs Holdings Inc. | 192.22 Million USD | -385.855% |
| Biomerica, Inc. | 785 Thousand USD | -118871.975% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -207678.715% |
| Bluejay Diagnostics, Inc. | 370.1 Thousand USD | -252241.903% |
| Silk Road Medical, Inc | 84.63 Million USD | -1003.506% |